A New Option in Migraine Prevention

Sponsored by Amgen / Novartis.

This activity is not certified for credit.

Date
Wednesday, September 5

Start Time
12:30p

End Time
1:30p

Room
Brera Ballroom
Level 3

Program Description

This product theater will provide an overview of a newly approved preventive treatment for migraine in adults. The program includes a conversation about the approved indication, important safety information, key findings from clinical trials, and other important prescribing information.

Faculty
Charles Argoff, MD

Contact Name
Tina C. Squillant, CMP

Contact Phone
(862) 246-3292

Contact email
tina.squillante@novartis.com

Share:

Related Content